REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medifarm Nitra S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Medifarm Nitra S.R.O. Profile Updated: July 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Medifarm Nitra S.R.O. is an enterprise in Slovakia, with the main office in Nitra. It operates in the Pharmacies and Drug Stores sector. The company was established on May 02, 1997. 3 - 4 (2025) employees currently work for Medifarm Nitra S.R.O.. In 2024, the company reported a net sales revenue drop of 25.89%. Over the same period, its total assets decreased by 54.41%. The net profit margin of Medifarm Nitra S.R.O. decreased by 0.98% in 2024.

Headquarters
Andreja Sulgana, 2
Nitra; Nitriansky; Postal Code: 94901

Contact Details: Purchase the Medifarm Nitra S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Medifarm Nitra S.R.O. report to view the information.
Registered Capital:
Purchase the Medifarm Nitra S.R.O. report to view the information.
Financial Auditors:
Purchase the Medifarm Nitra S.R.O. report to view the information.
Incorporation Date:
May 02, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medifarm Nitra S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-25.89%▼
Total operating revenue
-26.11%▼
Operating profit (EBIT)
-33.28%▼
EBITDA
-29.39%▼
Net Profit (Loss) for the Period
-33.47%▼
Total assets
-54.41%▼
Total equity
3.01%▲
Operating Profit Margin (ROS)
-1.24%▼
Net Profit Margin
-0.98%▼
Return on Equity (ROE)
-32.81%▼
Debt to Equity Ratio
-0.19%▼
Quick Ratio
27.84%▲
Cash Ratio
26.6%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo